Virtus Biotech ETF (BBP)

Assets	$136.32M
Expense Ratio	0.34%
PE Ratio	16.37
Forward PE	17.91
Shares Out	1.30M
Dividend	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	6,036
Open	101.98
Previous Close	102.51
Day's Range	101.98 - 101.98
52-Week Low	73.97
52-Week High	110.05
Beta	0.58
Holdings	68
Inception Date	Dec 17, 2014

About BBP

Fund Home Page

The Virtus Biotech ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is issued by Virtus Investment Partners.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NYSE Arca
• Ticker Symbol: BBP
• ETF Provider: Virtus Investment Partners
• Index Tracked: LifeSci Biotechnology Products Index

Top 10 Holdings

27.91% of assets

Name	Symbol	Weight
Moderna, Inc.	MRNA	6.10%
Xeris Biopharma Holdings, Inc.	XERS	3.23%
Omeros Corporation	OMER	2.71%
Verastem, Inc.	VSTM	2.71%
Iovance Biotherapeutics, Inc.	IOVA	2.46%
Kiniksa Pharmaceuticals International, plc	KNSA	2.44%
ADMA Biologics, Inc.	ADMA	2.12%
BeOne Medicines AG	ONC	2.07%
Regeneron Pharmaceuticals, Inc.	REGN	2.05%
Zai Lab Limited	ZLAB	2.01%

Performance

BBP had a total return of 30.98% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.16%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Nov 14, 2026

Data Sources Report a data error